ee

Registreeru
Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele.
Kodu・Aktsiate loetelu・Laboratorios Farmaceuticos Rovi SA
Search

Laboratorios Farmaceuticos Rovi SA

Suletud

80.2 1.84

Osta

Hinna uuendus 6. sept 2024, 15:29 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

80.15

Max

80.45

Põhinäitajad

By Trading Economics

Sissetulek

15M

Müük

-297M

151M

P/E

Sektori keskmine

24.61

Aktsiakasum

0.292

Kasumimarginaal

9.896

EBITDA

26M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+22.52 upside

Turustatistika

By TradingEconomics

Turukapital

-23M

4.1B

Eelmine avamishind

78.36

Eelmine sulgemishind

80.2

Uudiste sentiment

By Acuity

50%

50%

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

78.2 / N/A Toetus ja vastupanu

Laboratorios Farmaceuticos Rovi SA Graafik

Seotud uudised

7. sept 2024, 09:30 UTC

Peamised uudised

Jobs Slowdown Frustrates Investors Who Wanted Certainty on the Fed -- WSJ

DJ

Loe

7. sept 2024, 08:20 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Loe

6. sept 2024, 22:41 UTC

Market Talk

KinderCare and StandardAero File for IPOs -- Market Talk

DJ

Loe

6. sept 2024, 21:18 UTC

Peamised uudised

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- Update

DJ

Loe

6. sept 2024, 21:05 UTC

Peamised uudised

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 4th Update

DJ

Loe

6. sept 2024, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Loe

6. sept 2024, 20:39 UTC

Tulu

Update: NIO Stock Caught an Upgrade. Shares Rose. -- Barrons.com

DJ

Loe

6. sept 2024, 20:35 UTC

Peamised uudised

Stocks Extend Ugly Week of Losses Amid Economic Uncertainty -- WSJ

DJ

Loe

6. sept 2024, 20:34 UTC

Peamised uudised

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 3rd Update

DJ

Loe

6. sept 2024, 20:11 UTC

Peamised uudised

Stock Indexes Close Lower After Mixed Jobs Report -- WSJ

DJ

Loe

6. sept 2024, 19:51 UTC

Peamised uudised

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- WSJ

DJ

Loe

6. sept 2024, 19:16 UTC

Market Talk

U.S. Natural Gas Futures Hold Gains -- Market Talk

DJ

Loe

6. sept 2024, 19:14 UTC

Market Talk

Oil Futures Extend Losses on Demand Concerns -- Market Talk

DJ

Loe

6. sept 2024, 19:01 UTC

Market Talk

Gold Slips on Prevailing Uncertainty -- Market Talk

DJ

Loe

6. sept 2024, 18:27 UTC

Peamised uudised

JPMorgan Plans to Report Customers Who Exploited TikTok 'Glitch' to Authorities -- WSJ

DJ

Loe

6. sept 2024, 18:25 UTC

Market Talk

Broadcom Growth Views Conservative Amid AI Investments -- Market Talk

DJ

Loe

6. sept 2024, 18:15 UTC

Peamised uudised

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- Update

DJ

Loe

6. sept 2024, 18:12 UTC

Peamised uudised

Nasdaq Falls 2.5%, Leads Losses After Mixed Jobs Report -- WSJ

DJ

Loe

6. sept 2024, 17:44 UTC

Market Talk

Labor Costs Represent Diminishing Risk To Canada CPI, CIBC's Shenfeld Says -- Market Talk

DJ

Loe

6. sept 2024, 17:30 UTC

Market Talk

U.S Oil Rig Count Unchanged at 483 -- Market Talk

DJ

Loe

6. sept 2024, 17:30 UTC

Peamised uudised

Boeing's Starliner Is Returning to Earth Without Its Crew -- WSJ

DJ

Loe

6. sept 2024, 17:27 UTC

Peamised uudised

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- WSJ

DJ

Loe

6. sept 2024, 17:00 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Loe

6. sept 2024, 17:00 UTC

Market Talk

Mexican Inflation Seen Easing in August -- Market Talk

DJ

Loe

6. sept 2024, 16:36 UTC

Market Talk

Oil Futures Fall as U.S. Jobs Report Sinks In -- Market Talk

DJ

Loe

6. sept 2024, 16:35 UTC

Tulu
Kuumad aktsiad

Stocks to Watch Friday: Broadcom, Nvidia, UiPath, Smith & Wesson -- WSJ

DJ

Loe

6. sept 2024, 16:33 UTC

Omandamised, ülevõtmised, äriostud

Salesforce Stock Is on Pace for Longest Losing Streak Since 2008. An Acquisition Isn't Helping. -- Barrons.com

DJ

Loe

6. sept 2024, 16:20 UTC

Market Talk
Tulu

Tech, Media & Telecom Roundup: Market Talk

DJ

Loe

6. sept 2024, 16:20 UTC

Tulu

Oracle Profit, Revenue Set to Rise in 1Q -- Earnings Preview

DJ

Loe

6. sept 2024, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Loe

Laboratorios Farmaceuticos Rovi SA Prognoos

Hinnasiht

By TipRanks

22.52% tõus

12 kuu keskmine prognoos

Keskmine 99 EUR  22.52%

Kõrge 104 EUR

Madal 94 EUR

Põhineb 2 Wall Streeti analüütiku instrumendi Laboratorios Farmaceuticos Rovi SA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

2

Osta

0

Hoia

0

Müü

Põhineb 2 analüütiku instrumendi Laboratorios Farmaceuticos Rovi SA aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

78.2 / N/AToetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Keskpikk perspektiiv

Bearish Evidence

Bearish events outweigh bullish events.

Pikk perspektiiv

Weak Bullish Evidence

All events are bullish.

Sentiment

By Acuity

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

EBITDA

Ärikasum

$

Ettevõttest Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast mediums for use in magnetic resonance, ultrasound and X-ray diagnostics; Prescription, which distributes medicines under such brands as Hibor, Osseor, Hepadren, Pneumovax-23, Glufan, Corlentor, Exxiv, Calcio y Vitamina D3 Rovi and Absorcol, among others; and Over The Counter (OTC), which comprises the Perspirex, Enerzona, Dentimelo and ColdPack brands. The Company owns such fully consolidated subsidiaries as Gineladius SL, Frosst Iberica SA, Rovi Contract Manufacturing SL and Bertex Pharma GmbH, among others.